Continuous Monitoring of Vital Signs to Understand Perioperative Heart Injury After Major Non-Heart Surgery in High-Risk Patients
Led by University Hospital, Basel, Switzerland · Updated on 2025-01-28
875
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What this Trial Is About
This research aims to better understand perioperative myocardial infarctioninjury PMI in high-risk patients undergoing major non-cardiac surgery. PMI is a significant contributor to deaths following surgery and includes various underlying causes such as heart attacks, oxygen supply issues, arrhythmias, heart failure, and conditions outside the heart like sepsis or stroke. The study focuses on uncovering the triggers of PMI by using continuous vital sign monitoring and blood tests, as the exact causes remain unclear in many cases.
Participants will wear a multi-sensor wearable device called the Basler Band to continuously monitor vital signs such as heart rate, heart rhythm, respiration, and activity for up to seven days after surgery or until hospital discharge. Blood samples will be taken before surgery and on the first two days after surgery to analyze biomarkers. The study also validates the wearable devices accuracy by comparing its measurements to routine clinical data. One year after surgery, participants will answer a questionnaire to provide additional information.
During the study, participants will have blood drawn three times and wear the Basler Band to record continuous vital signs. Researchers will track heart rhythm abnormalities, blood pressure changes, oxygen levels, and other key measures during and after surgery. They will also assess major adverse cardiac and cerebrovascular events up to one year later. The overall participation lasts about one week, plus the follow-up questionnaire after one year. Biological samples collected will be stored for future research under strict privacy protections.
CONDITIONS
Brief Title
Monitoring of Vital Signs for Phenotyping of Perioperative Myocardial Infarction/Injury After Noncardiac Surgery
Research Team
C
Christian Müller, MD, Prof
C
Christian Puelacher, MD-PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patient requiring hospitalisation with 65 2 overnight stays after surgery
Age 65 40 years to 64 85 AND history of coronary artery disease (CAD), peripheral artery disease (PAD), cerebrovascular disease/stroke, insulin-dependent diabetes mellitus (IDDM), or chronic heart failure (CHF)
Elective surgery
Patients undergoing orthopaedic, traumatology, vascular, spinal, thoracic, neurosurgical, urological or visceral surgery
Patient consent available
You will not qualify if you...
Patient's refusal
Heart surgery, cardiac arrest, acute mycardial infarction (AMI), cardiac valve intervention, or cardiac catheter ablation within 14 days prior to surgery OR involvement of heart surgery at index surgery OR surgery planned on cardiopulmonary bypass
Patients undergoing plastic/reconstructive, ophthalmologic, dental, hand surgery, or ear-nose-and-throat surgery
Chronic renal failure on dialysis, unless undergoing renal transplant surgery
Moderate to severe dementia
Inclusion into study within the last year
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - From surgery day up to 7 days after surgery or until hospital discharge
Participants will wear a multi-sensor wearable device to continuously monitor vital signs such as heart rate, heart rhythm, respiration rate, and activity during and after surgery to help identify perioperative myocardial infarction/injury.
Continuous monitoring with wearable device during hospital stay
Sample Collection
Duration - 3 days around surgery
Venous blood samples are collected before surgery and on postoperative days 1 and 2 to evaluate biochemical markers and validate diagnoses related to myocardial injury.
3 blood draws coordinated with routine clinical blood draws
Long-term Monitoring
Duration - 1 year after surgery
Participants will answer a follow-up questionnaire approximately one year after surgery to assess major adverse cardiac and cerebral events and other outcomes.
1 follow-up questionnaire
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Study of Myocardial Injury Caused by Anesthesia in Adults Aged 40 to 80 Undergoing Non-Heart Surgery
Landiolol Use to Control Heart Rate in Patients Aged 45 and Older at Risk of Heart Problems Undergoing Major Non-Cardiac Surgery A Feasibility Study
Continuous Monitoring of Vital Signs to Understand Perioperative Heart Injury After Major Non-Heart Surgery in High-Risk Patients
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Perioperative discontinuation of SGLT2-inhibitors and cardiac complications after noncardiac surgery: secondary analysis of two prospective observational cohort studies.